<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04267796</url>
  </required_header>
  <id_info>
    <org_study_id>2019-0634</org_study_id>
    <secondary_id>NCI-2019-07636</secondary_id>
    <secondary_id>2019-0634</secondary_id>
    <nct_id>NCT04267796</nct_id>
  </id_info>
  <brief_title>Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women</brief_title>
  <official_title>Reducing Breast Cancer Risk Through Modifying Body Composition and Decreasing Inflammation in Normal Weight Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Foundation for Women's Cancers</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies how well a lifestyle intervention works in reducing breast cancer risk&#xD;
      through changing body composition and decreasing inflammation in normal weight women. This&#xD;
      trial may help researchers learn more about diet and exercise programs designed to decrease&#xD;
      body fat in postmenopausal women who are of normal weight but have an elevated risk of breast&#xD;
      cancer because of excess body fat.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. Evaluate the feasibility of a diet and exercise intervention to decrease body fat in&#xD;
      postmenopausal women with normal body mass index (BMI) but high body fat (trunk fat mass 9.4&#xD;
      kg, the 50th percentile of normal BMI women in the Women's Health Initiative [WHI]).&#xD;
&#xD;
      SECONDARY OBJECTIVE:&#xD;
&#xD;
      I. Assess preliminary efficacy of the intervention by evaluating the post-intervention&#xD;
      differences between the intervention and control groups in:&#xD;
&#xD;
      IIa. Circulating markers of inflammation and metabolic dysfunction linked to both excess&#xD;
      adiposity and breast cancer (high sensitivity C-reactive protein [hsCRP], fasting insulin,&#xD;
      leptin, IL-6, triglycerides, sex hormone binding globulin [SHBG], adiponectin, and high&#xD;
      density lipoprotein [HDL] cholesterol).&#xD;
&#xD;
      IIb. Body composition body fat, trunk fat mass, fat mass, lean mass, fat-free mass).&#xD;
&#xD;
      EXPLORATORY OBJECTIVE:&#xD;
&#xD;
      I. Exploratory outcomes include fitness (oxygen consumption VO2 peak, sit-to-stand test),&#xD;
      behavior (physical activity, energy intake, macronutrient consumption), and quality of life&#xD;
      (global health-related quality of life, physical functioning, sleep, menopausal symptoms).&#xD;
&#xD;
      OUTLINE: Participants are randomized to 1 of 2 groups.&#xD;
&#xD;
      GROUP I: Participants complete lifestyle intervention consisting of 1-3 sets of&#xD;
      high-resistance circuit training sessions per week, up to 150 minutes of aerobic training per&#xD;
      week, and diet recommendations from a health coach or registered dietitian twice per week for&#xD;
      16 weeks.&#xD;
&#xD;
      GROUP II: Participants are placed on a wait-list and then complete lifestyle intervention&#xD;
      after 4 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the feasibility of a diet intervention to decrease body fat in postmenopausal women with normal BMI but high body. fat.</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>Will assessed by the calculated rates, frequencies, and 95% confidence intervals (CIs) for these measures</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Evaluate the exercise intervention to decrease body fat in postmenopausal women with normal BMI but high body. fat.</measure>
    <time_frame>up to 16 weeks</time_frame>
    <description>Will assessed by the calculated rates, frequencies, and 95% confidence intervals (CIs) for these measures</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">62</enrollment>
  <condition>Breast Carcinoma</condition>
  <arm_group>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants complete lifestyle intervention consisting of 1-3 sets of high-resistance circuit training sessions per week, up to 150 minutes of aerobic training per week, and diet recommendations from a health coach or registered dietitian twice per week for 16 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants are placed on a wait-list and then complete lifestyle intervention after 4 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Aerobic Exercise</intervention_name>
    <description>Complete aerobic training</description>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
    <other_name>Aerobic Activity</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Receive diet recommendations from health coach or registered dietitian</description>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
    <other_name>Dietary Modification</other_name>
    <other_name>intervention, dietary</other_name>
    <other_name>Nutrition Intervention</other_name>
    <other_name>Nutrition Interventions</other_name>
    <other_name>Nutritional Interventions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Resistance Training</intervention_name>
    <description>Complete high-resistance circuit training sessions</description>
    <arm_group_label>Group I (lifestyle intervention)</arm_group_label>
    <arm_group_label>Group II (wait-list, lifestyle intervention)</arm_group_label>
    <other_name>Strength Training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Employee at MD Anderson Cancer Center&#xD;
&#xD;
          -  Age between 50-69 years old&#xD;
&#xD;
          -  Postmenopausal woman (absence of menstruation for at least one year, or history of&#xD;
             bilateral oophorectomy)&#xD;
&#xD;
          -  Self-reported height and weight indicating a BMI of at least 18.5 and &lt; 25 kg/m^2&#xD;
&#xD;
          -  No contraindications to exercise (either no positive responses on the Physical&#xD;
             Activity Readiness Questionnaire, or clearance from a health care provider certifying&#xD;
             that the participant is healthy enough to exercise)&#xD;
&#xD;
          -  Not currently adhering to national physical activity guidelines (150 minutes per week&#xD;
             of moderate intensity aerobic exercise or 75 minutes per week of vigorous intensity&#xD;
             exercise, strength exercise twice a week)&#xD;
&#xD;
          -  No history of invasive cancer, other than non-melanoma skin cancer&#xD;
&#xD;
          -  No history of renal disease&#xD;
&#xD;
          -  Able to walk without an assistive device&#xD;
&#xD;
          -  Not within 3 months of major surgery&#xD;
&#xD;
          -  Able to speak/read/write in English&#xD;
&#xD;
          -  Has internet access on a computer or mobile device&#xD;
&#xD;
          -  A trunk mass greater than or equal to 9.4 kg as indicated by a dual X-ray&#xD;
             absorptiometry (DXA) scan&#xD;
&#xD;
          -  Height and weight indicating a BMI of at least 18.5 and &lt; 25 kg/m^2 verified at the&#xD;
             screening visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  MD Anderson employees that report to the principal investigator of this study&#xD;
&#xD;
          -  Participants that cannot engage in the exercise program for more than three weeks&#xD;
             during the study period&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen M Basen-Engquist</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Karen M. Basen-Engquist</last_name>
    <phone>713-745-3123</phone>
    <email>kbasenen@mdanderson.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen M. Basen-Engquist</last_name>
      <phone>713-745-3123</phone>
    </contact>
    <investigator>
      <last_name>Karen M. Basen-Engquist</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 26, 2019</study_first_submitted>
  <study_first_submitted_qc>February 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2020</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

